MBRX Company Profile and Key Details

Q: Who are the executives of MBRX?

Mr. Walter V. KlempFounder, Chairman, Pres & Chief Executive OfficerMr. Jonathan P. Foster CPAExecutive Vice President & Chief Financial OfficerMs. Jacqueline NorthcutConsultantMr. Louis Ploth Jr.Independent AdvisorDr. Robert C. Shepard FACP, M.D., F.A.C.P.Chief Medical Officer of AnnamycinDr. Wolfram C. M. Dempke M.B.A., M.D., Ph.D.European Chief Medical OfficerDr. John Paul Waymack M.D., Sc.D.Senior Chief Medical Officer

NASDAQ : MBRX

Moleculin Biotech

$2.56

0.05+1.99%

At Close 4:00 PM

66.54

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Moleculin Biotech, Inc. (MBRX) stock declined over -1.95%, trading at $2.51 on NASDAQ, down from the previous close of $2.56. The stock opened at $2.52, fluctuating between $2.49 and $2.58 in the recent session.

Stock Snapshot

2.56

Prev. Close

3.03M

Market Cap

2.49

Day Low

-0.09

P/E Ratio

-28.42

EPS (TTM)

-12.09

Cash Flow per Share

2.52

Open

1.21M

Number of Shares

2.58

Day High

97.14%

Free Float in %

13.01

Book Value

24.94K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Apr 30, 2026	2.46	2.58	2.46	2.56	69.86K
Apr 29, 2026	2.56	2.56	2.45	2.51	74.96K
Apr 28, 2026	2.56	2.62	2.50	2.56	132.83K
Apr 27, 2026	2.55	2.56	2.46	2.54	100.47K
Apr 23, 2026	2.47	2.58	2.29	2.54	547.85K
Apr 22, 2026	2.54	2.54	2.42	2.50	57.87K
Apr 21, 2026	2.57	2.60	2.47	2.53	58.89K
Apr 20, 2026	2.41	2.58	2.34	2.56	110.79K
Apr 17, 2026	2.44	2.48	2.38	2.42	95.42K
Apr 16, 2026	2.37	2.44	2.36	2.40	108.62K
Apr 14, 2026	2.72	2.72	2.44	2.49	154.97K
Apr 13, 2026	2.62	2.77	2.59	2.72	68.09K
Apr 10, 2026	2.54	2.65	2.52	2.62	53.81K
Apr 09, 2026	2.44	2.58	2.42	2.55	109.76K
Apr 08, 2026	2.44	2.61	2.41	2.43	81.98K
Apr 07, 2026	2.33	2.44	2.33	2.41	67.73K
Apr 06, 2026	2.30	2.35	2.26	2.32	41.18K
Apr 02, 2026	2.18	2.33	2.18	2.32	59.66K
Apr 01, 2026	2.26	2.30	2.20	2.23	58.69K
Mar 31, 2026	2.27	2.32	2.20	2.29	76.27K

Contact Details

Houston, TX 77007

United States

https://www.moleculin.com 713 300 5160

About Company

Moleculin Biotech, Inc., a clinical-stage pharmaceutical company, focuses on the development of drug candidates for the treatment of highly resistant tumors and viruses. Its lead drug candidate is Annamycin that is in Phase 1/2 studies for the treatment of relapsed or refractory acute myeloid leukemia (AML) and cancers metastasized to the lungs. The company's flagship immune/transcription modulator is WP1066, which is in Phase I clinical trial for the treatment of brain tumors and pediatric brain tumors, as well as pancreatic cancer and other malignancies. It also develops WP1220, an analog of WP1066 for the topical treatment of cutaneous T-cell lymphoma; and WP1122 to treat glioblastoma multiforme and COVID-19. The company has partnership and collaboration agreements with MD Anderson; Animal Life Sciences, LLC; and WPD Pharmaceuticals Sp z.o.o. Moleculin Biotech, Inc. was incorporated in 2015 and is headquartered in Houston, Texas.

Stock Peers

ARGX

5.7+0.73%

argenx SE$781.72 REGN

20.7+3.02%

Regeneron Pharmaceuticals, Inc.$707.06 UTHR

0.28+0.05%

United Therapeutics Corporation$571.35 MDGL

-1.19-0.23%

Madrigal Pharmaceuticals, Inc.$517.39 VRTX

4.14+0.98%

Vertex Pharmaceuticals Incorporated$427.38 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 PRAX

-4.36-1.35%

Praxis Precision Medicines, Inc.$318.83 ALNY

8.3+2.76%

Alnylam Pharmaceuticals, Inc.$309.49 KRYS

2.31+0.89%

Krystal Biotech, Inc.$262.26 LGND

4.59+2.04%

Ligand Pharmaceuticals Incorporated$229.45

Frequently Asked Questions

What is the current Moleculin Biotech, Inc. (MBRX) stock price?

Moleculin Biotech, Inc. (NASDAQ: MBRX) stock price is $2.51 in the last trading session. During the trading session, MBRX stock reached the peak price of $2.58 while $2.49 was the lowest point it dropped to. The percentage change in MBRX stock occurred in the recent session was -1.95% while the dollar amount for the price change in MBRX stock was - $0.05.

MBRX's industry and sector of operation?

The NASDAQ listed MBRX is part of Biotechnology industry that operates in the broader Healthcare sector. Moleculin Biotech, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of MBRX?

Mr. Walter V. Klemp
Founder, Chairman, Pres & Chief Executive Officer
Mr. Jonathan P. Foster CPA
Executive Vice President & Chief Financial Officer
Ms. Jacqueline Northcut
Consultant
Mr. Louis Ploth Jr.
Independent Advisor
Dr. Robert C. Shepard FACP, M.D., F.A.C.P.
Chief Medical Officer of Annamycin
Dr. Wolfram C. M. Dempke M.B.A., M.D., Ph.D.
European Chief Medical Officer
Dr. John Paul Waymack M.D., Sc.D.
Senior Chief Medical Officer

How MBRX did perform over past 52-week?

MBRX's closing price is 43.02% higher than its 52-week low of $1.79 where as its distance from 52-week high of $28.60 is -91.05%.

How many employees does MBRX have?

Number of MBRX employees currently stands at 17.

Link for MBRX official website?

Official Website of MBRX is: https://www.moleculin.com

How do I contact MBRX?

MBRX could be contacted at phone 713 300 5160 and can also be accessed through its website. MBRX operates from 5300 Memorial Drive, Houston, TX 77007, United States.

How many shares of MBRX are traded daily?

MBRX stock volume for the day was 24.94K shares. The average number of MBRX shares traded daily for last 3 months was 160.97K.

What is the market cap of MBRX currently?

The market value of MBRX currently stands at $3.03M with its latest stock price at $2.51 and 1.21M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	17
Beta	1.74
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	17
Beta	1.74
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

MBRX Company Profile and Key Details

Moleculin Biotech

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Shareholding & Insider Activity

Earnings & Analyst Outlook

Dividend & Fair Value

Company Overview

Financial & Profitability Overview

Quarterly Financial Highlights

Valuation Metrics

Key Takeaways

Price Forecast & Outlook